April 16, 2018
The U.S. Supreme Court on Monday called for the Trump administration's views in a major False Claims Act case involving Gilead Sciences Inc., suggesting that the high court may soon revisit its landmark Escobar decision.
March 05, 2018
Gilead Sciences Inc. is trying to escape a multibillion-dollar False Claims Act suit by wrongly asserting that the federal government clearly kept buying drugs despite knowledge of manufacturing violations, whistleblowers told the U.S. Supreme Court on Monday.
February 02, 2018
The U.S. Chamber of Commerce is pushing the U.S. Supreme Court to review a Ninth Circuit ruling that let False Claims Act litigation proceed against Gilead Sciences Inc., saying the ruling "disregarded" key elements of the high court's Escobar decision.
January 04, 2018
Gilead Sciences is urging the U.S. Supreme Court to review a Ninth Circuit decision that let a False Claims Act suit proceed even though regulators didn't halt drug reimbursement after learning of alleged fraud, saying the decision makes it "impossible" to quickly beat cases.